Want to see TSE:KPT full AI Analyst Report?
KPT Stock Chart & Stats
C$12.76
C$0.20(1.57%)
At close: 4:00 PM EDT
C$12.76
C$0.20(1.57%)
Day’s Range― - ―
52-Week RangeC$9.12 - C$13.78
Previous CloseN/A
Volume9.12K
Average Volume (3M)17.75K
Market Cap
C$127.51M
Enterprise ValueC$132.56
Total Cash (Recent Filing)C$0.00
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)14.3
Beta0.26
Next Earnings
Nov 11, 2026EPS Estimate
0.29Next Dividend Ex-DateN/A
Dividend Yield5.95%
Share Statistics
EPS (TTM)0.89
Shares Outstanding10,032,387
10 Day Avg. Volume14,081
30 Day Avg. Volume17,752
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)1.47
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$13.50Price Target Upside5.80% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)1.02
Revenue Forecast (FY)C$2.27B
Bulls Say, Bears Say
Bulls Say
Profitability Recovery And Margin ExpansionThe sustained recovery from prior loss years and stronger EBITDA margin indicate improved operating execution. If maintained, higher profitability should strengthen the company’s ability to fund operations and strategic investment.
U.S. Growth And Capacity ExpansionU.S. growth diversifies KP Tissue beyond its softer Canadian market, while added Memphis capacity can support future volumes, productivity and service levels as the facility approaches maturity.
Strong Canadian Facial Tissue Position And InnovationA leading category position and continued product innovation provide durable brand visibility and customer relevance. These advantages can support pricing, defend shelf space and improve resilience against private-label competition.
Bears Say
Canadian Consumer Share ErosionThe decline signals pressure in an important home market, where private-label substitution can weaken volumes, pricing and brand economics. Recovery actions may take time and could require sustained promotional or marketing investment.
AFH Margin And Input-cost PressureFreight inflation and volatile pulp costs can structurally pressure margins across tissue products. Planned AFH price increases may recover some costs, but customer resistance or further input inflation could limit pass-through.
Cash Flow Visibility And Liquidity UncertaintyThe quarterly cash decline and incomplete recent cash-flow reporting make current cash conversion harder to assess. Persistent working-capital needs could constrain flexibility for capital projects, distributions or unexpected cost increases.
KP Tissue News
KPT FAQ
What was KP Tissue Inc.’s price range in the past 12 months?
KP Tissue Inc. lowest stock price was C$9.12 and its highest was C$13.78 in the past 12 months.
What is KP Tissue Inc.’s market cap?
KP Tissue Inc.’s market cap is C$127.51M.
When is KP Tissue Inc.’s upcoming earnings report date?
KP Tissue Inc.’s upcoming earnings report date is Nov 11, 2026 which is in 77 days.
How were KP Tissue Inc.’s earnings last quarter?
KP Tissue Inc. released its earnings results on Aug 13, 2026. The company reported C$1.854 earnings per share for the quarter, beating the consensus estimate of C$0.263 by C$1.591.
Is KP Tissue Inc. overvalued?
According to Wall Street analysts KP Tissue Inc.’s price is currently Undervalued.
Does KP Tissue Inc. pay dividends?
KP Tissue Inc. pays a Quarterly dividend of C$0.21 which represents an annual dividend yield of 5.95%. See more information on KP Tissue Inc. dividends here
What is KP Tissue Inc.’s EPS estimate?
KP Tissue Inc.’s EPS estimate is 0.29.
How many shares outstanding does KP Tissue Inc. have?
KP Tissue Inc. has 10,032,387 shares outstanding.
What happened to KP Tissue Inc.’s price movement after its last earnings report?
KP Tissue Inc. reported an EPS of C$1.854 in its last earnings report, beating expectations of C$0.263. Following the earnings report the stock price went up 1.253%.
Which hedge fund is a major shareholder of KP Tissue Inc.?
Currently, no hedge funds are holding shares in TSE:KPT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
KP Tissue Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
C$13.50 (5.80% Upside)
C$13.50 (5.80% Upside)
Insider Transactions
Sold Shares
Worth C$87.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.28%
12-Months-Change
Fundamentals
Return on Equity
5.95%
Trailing 12-Months
Asset Growth
6.10%
Trailing 12-Months
Company Description
KP Tissue Inc.
KP Tissue Inc. conducts its core operations through its investment in Kruger Products L.P., focusing on the creation, dissemination, and sale of a diverse range of disposable tissue products throughout Canada and the United States. The company divides its business into two primary segments: Consumer and Away-From-Home. Its product lineup encompasses bath tissue, facial tissue, paper towels, and napkins. Additionally, KP Tissue manufactures private-label tissue items. These offerings are marketed under various prominent brands, including Cashmere, Purex, SpongeTowels, Scotties, White Swan, White Cloud, Chalet, Embassy, and Metro. For individual consumers, products are distributed via conventional retail outlets such as grocery chains, mass merchandisers, club and drug stores, convenience shops, and e-commerce platforms. Conversely, businesses and institutions in commercial sectors like property management, healthcare, food services, manufacturing, hospitality, and public facilities obtain their supplies through an established network of distributors. KP Tissue Inc. was founded in 2012 and is headquartered in Mississauga, Canada.
KPT Stock 12 Month Forecast
Average Price Target
C$13.50
▲(5.80% Upside)